Association Between Menopausal Estrogen-Only Therapy and Ovarian Carcinoma Risk. - Wikidata - awgldk - TriplyDB

Association Between Menopausal Estrogen-Only Therapy and Ovarian Carcinoma Risk.

Association Between Menopausal Estrogen-Only Therapy and Ovarian Carcinoma Risk.

http://www.wikidata.org/entity/Q30277016

about

Ovarian cancer epidemiology in the era of collaborative team science.A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancer Major clinical research advances in gynecologic cancer in 2016: 10-year special edition.A prospective study of reproductive factors and exogenous hormone use in relation to ovarian cancer risk among Black women.A general description for Chinese medicine in treating premature ovarian failure.Global trends and predictions in ovarian cancer mortality.Preclinical Models of Ovarian Cancer: Pathogenesis, Problems, and Implications for Prevention.Premenopausal Hysterectomy and Risk of Ovarian Cancer in African-American Women.Challenges and Opportunities in Studying the Epidemiology of Ovarian Cancer Subtypes.

P2860

Q30252987-424C9C96-F9B4-4E4D-BDF8-C9F99AF51A5C Q30276359-8FA0BA06-D443-423F-9D3A-F2819A7B553A Q33563963-F1340472-EAEE-4E2E-B273-2F3D0B802DC2 Q39062995-EDB8A3C9-04F4-4787-80EB-F48670F115C5 Q39164979-641BCA37-B76A-449B-8FE0-9AA60D5EC5F5 Q39420632-F6C7569B-355D-40AB-BCAE-630F4A9195D7 Q39441988-ED47650E-9DA9-452E-A9DF-31E5F5ABA455 Q40227579-CD72DCE2-C914-4B6E-A0BC-6523520BF8DD Q45933729-9C991D02-F791-4BD9-A11E-32D8F8D0AE43

P2860

Association Between Menopausal Estrogen-Only Therapy and Ovarian Carcinoma Risk.

http://www.wikidata.org/entity/Q30277016

description

2016 nî lūn-bûn

@nan

2016 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Association Between Menopausal Estrogen-Only Therapy and Ovarian Carcinoma Risk.

@ast

Association Between Menopausal Estrogen-Only Therapy and Ovarian Carcinoma Risk.

@en

type

label

Association Between Menopausal Estrogen-Only Therapy and Ovarian Carcinoma Risk.

@ast

Association Between Menopausal Estrogen-Only Therapy and Ovarian Carcinoma Risk.

@en

prefLabel

Association Between Menopausal Estrogen-Only Therapy and Ovarian Carcinoma Risk.

@ast

Association Between Menopausal Estrogen-Only Therapy and Ovarian Carcinoma Risk.

@en

P1433

Q30277016-89C22750-F164-47F3-95DB-CEDCE963AA0B

P1476

Q30277016-AC66AFC2-917C-4BA8-934D-C090553E0F0E

P2093

Q30277016-14B51B47-8439-44E9-883F-92E27E440068

Q30277016-27F55B1A-A69D-4F93-8471-C7B5AA9F106B

Q30277016-344CC5F1-F3BA-4542-9321-E124402AA507

Q30277016-3BBF5B0B-B454-46D1-98C6-596FD22851F6

Q30277016-3C30CF25-8F6C-44FD-A770-1D3A42DA1A51

Q30277016-4920F62F-8421-4290-BDE0-19A25505187B

Q30277016-4D7558F8-D8BC-4A26-A590-A1CED555A1AC

Q30277016-51EE6BF3-F05B-42D4-83B9-6C1F677DB2EE

Q30277016-52449738-80FD-40EE-9CC5-E977DD9D6FC9

Q30277016-52EC8757-7BFD-4432-8DEC-A77A2787FBD8

P2860

Q30277016-06A2B559-AE6C-4874-846D-41D8D7042990

Q30277016-12117A29-C6A7-41B6-99E0-61C30DCFAF20

Q30277016-13B0C111-F58D-40A1-AAF0-3FDBC1472992

Q30277016-1A9D1FB3-2A57-4A30-9D26-41F3ADF7551D

Q30277016-25483797-92E3-4B42-A0D8-6B632DA88878

Q30277016-2DC4B36D-08F4-410B-94D6-8A413F84BF63

Q30277016-39DC50F0-DD78-467F-B4EC-489674F73A24

Q30277016-3A6BD811-74C5-4627-994D-486E7D858B86

Q30277016-3D1EA865-2950-48EB-B5DC-DE8571A236C3

Q30277016-3F90859A-F529-4E89-B28C-09FE88A96197

P304

Q30277016-B24B96BF-2727-40DF-9A82-A10EFB225266

P31

Q30277016-680527CB-2779-4587-92EF-A7F2CC64429F

P356

Q30277016-7125263F-B9A5-455A-B766-B3211D31D983

P407

Q30277016-760E7A56-92CF-44CC-9080-3A50E8D6CBE4

P433

Q30277016-6CA2CF1E-D2D8-4F05-BCB7-E374F15347C4

P478

Q30277016-A307417F-C5C6-48D5-8FF3-0A997FEBD2BE

P50

Q30277016-1801F27D-744D-47F3-B860-6B642D7CF065

Q30277016-53285C55-1562-472C-801F-8889DBA92CD6

Q30277016-7D737908-445B-4864-A0CC-A3E51ABE6CFD

Q30277016-84CCFB2C-682C-4A70-AB20-AAC9D9206ABB

Q30277016-B146DFD7-048E-4700-BF31-B45F1CD558F6

Q30277016-C104FA34-6034-4C53-BF89-033966B7056D

Q30277016-DC32E7DF-10E8-440F-85D1-66DCA922B3C5

Q30277016-EC139E7C-CE74-47D8-A02F-686AC6A339C2

Q30277016-FA4AF075-F4E4-41EB-B10D-1FC8143ECF80

P577

Q30277016-DD663C43-7910-44B9-B998-631DC0945EFE

P698

Q30277016-CB6B9277-F32D-4410-81EB-D49ABF7605FC

P932

Q30277016-A57116AD-00D3-4FBD-A657-163EF8096F26

P356

AOG.0000000000001387

P1433

Obstetrics and Gynecology

P1476

Association Between Menopausal Estrogen-Only Therapy and Ovarian Carcinoma Risk.

@en

P2093

Alice W Lee

http://www.w3.org/2001/XMLSchema#string

Andrew Berchuck

http://www.w3.org/2001/XMLSchema#string

Anna H Wu

http://www.w3.org/2001/XMLSchema#string

Celeste Leigh Pearce

http://www.w3.org/2001/XMLSchema#string

Daniel O Stram

http://www.w3.org/2001/XMLSchema#string

Daniel W Cramer

http://www.w3.org/2001/XMLSchema#string

Estrid Hogdall

http://www.w3.org/2001/XMLSchema#string

Harvey Risch

http://www.w3.org/2001/XMLSchema#string

Jennifer A Doherty

http://www.w3.org/2001/XMLSchema#string

Kara L Cushing-Haugen

http://www.w3.org/2001/XMLSchema#string

P2860

Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies

Estrogen, progesterone and epithelial ovarian cancer

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

A prospective study of postmenopausal hormone use and ovarian cancer risk

Agreement of self-reported estrogen use with prescription data: an analysis of women from the Kuopio Osteoporosis Risk Factor and Prevention Study .

National use of postmenopausal hormone therapy: annual trends and response to recent evidence.

Androgen receptor cytosine, adenine, guanine repeats, and haplotypes in relation to ovarian cancer risk

Markers of inflammation and risk of ovarian cancer in Los Angeles County

Increased ovarian cancer risk associated with menopausal estrogen therapy is reduced by adding a progestin.

Endometrial cancer and hormone-replacement therapy in the Million Women Study.

P304

828-836

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/AOG.0000000000001387

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

127

http://www.w3.org/2001/XMLSchema#string

P50

Jenny Chang-Claude

Aleksandra Gentry-Maharaj

Francesmary Modugno

Joellen M Schildkraut

Mary Anne Rossing

P577

2016-04-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27054934

http://www.w3.org/2001/XMLSchema#string

P932

4892111

http://www.w3.org/2001/XMLSchema#string